Results 1 to 10 of about 2,745 (117)
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
Remission induction in antineutrophil cytoplasmic autoantibody (ANCA) vasculitis may be complicated by slow response to treatment and toxicity from glucocorticoids.
Frank B. Cortazar +6 more
doaj +3 more sources
Methotrexate for induction of remission in ulcerative colitis [PDF]
Ulcerative colitis (UC) is a chronic inflammatory bowel disease. Corticosteroids and 5-aminosalicylates are the most commonly used therapies. However, many patients require immunosuppressive therapy for steroid-refractory and steroid-dependent disease.
Nilesh, Chande +3 more
openaire +2 more sources
Serum ferritin is a good indicator for predicting the efficacy of adult HLH induction therapy
Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome with a high mortality rate. There is no biomarker to predict the early therapeutic response.
Zhengjie Hua +5 more
doaj +1 more source
Introduction: Treatment of lupus nephritis consists of six months of induction immunosuppression followed by years of maintenance immunosuppression.
Shailendra Shrestha, Rahul Yadav
doaj +1 more source
Remission induction in acute myeloid leukemia [PDF]
Inducing a complete remission (CR) in patients with acute myeloid leukemia is a prerequisite to long-term disease control with subsequent post-remission consolidation chemotherapy or allogeneic hematopoietic stem cell transplantation. The use of 7 days of infusional cytarabine and 3 days of daunorubicin or idarubicin (7 + 3) has become the standard of ...
Eytan M, Stein, Martin S, Tallman
openaire +2 more sources
Background: The therapeutic role of methotrexate (MTX) for management of inflammatory bowel disease (IBD) remains unclear. Methods: We systematically reviewed randomized, controlled trials (RCTs) of MTX for induction and maintenance of remission in IBD ...
Ole Haagen Nielsen +3 more
doaj +1 more source
Natalizumab for induction of remission in Crohn's disease [PDF]
This systematic review update summarizes the current evidence on the use of natalizumab for induction of remission in Crohn's disease (CD).To determine the efficacy and safety of natalizumab for induction of remission in CD.We searched MEDLINE, Embase, CENTRAL, the Cochrane IBD Group Specialized Trials Register, and clinicaltrials.gov from inception to
Seana Ml, Nelson +3 more
openaire +2 more sources
Background To determine the prevalence of sustained remission/low disease activity (LDA) in patients with rheumatoid arthritis (RA) after discontinuation of tumor necrosis factor inhibitors (TNFi), separately in induction treatment and maintenance ...
Michael M. Ward +4 more
doaj +1 more source
Probiotics for induction of remission in Crohn's disease
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract, in which the pathogenesis is believed to be partly influenced by the gut microbiome. Probiotics can be used to manipulate the microbiome and have therefore been considered as a potential therapy for CD.
Limketkai, Berkeley N +3 more
openaire +3 more sources
Background The aim of this study was to assess the outcomes of remission induction in patients with IgG4-related disease (IgG4-RD) in our cohort, and to investigate the characteristics, prognosis, and risk factors in the patients failed of remission ...
Liwen Wang +11 more
doaj +1 more source

